U.S. Department of Defense
Denewsnov25 4 Promo

Pfizer and Moderna Ready COVID-19 Vaccines

Dec. 2, 2020
The pharmaceutical industry gears up to deliver COVID-19 vaccines, ultracold dry ice and all.

As part of Operation Warp Speed, which is developing vaccines for the COVID-19 coronavirus, pharmaceutical companies Pfizer and Moderna are rehearsing the process of registering vaccines for different administration sites. Pfizer, for example, is practicing delivering their vaccine throughout different administration sites and learning lessons to aid those who must dispense the vaccine. The training is taking place in 54 different locations.

Moderna is also going through training for their vaccine for different jurisdictions, although the storage requirements for their COVID-19 coronavirus vaccine are far less rigorous than for the Pfizer vaccine. Whereas the Pfizer vaccine must be stored at ultracold temperatures, such as with dry ice, the Moderna vaccine can be stored for longer times and at standard ice refrigeration temperatures. This long-term storage of the Moderna COVID-19 vaccine at standard refrigeration temperatures helps it remain stable when attempting to reach extremely rural areas with the vaccine. Both companies are learning from these training sessions for developing administration literature and videos.